GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Institutional Ownership

Daxor (FRA:DX5) Institutional Ownership : 2.21% (As of Jun. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Daxor Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Daxor's institutional ownership is 2.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Daxor's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Daxor's Float Percentage Of Total Shares Outstanding is 42.66%.


Daxor Institutional Ownership Historical Data

The historical data trend for Daxor's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daxor Institutional Ownership Chart

Daxor Historical Data

The historical data trend for Daxor can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 3.19 3.20 3.16 2.18 2.20 2.21 2.17 2.21 2.21 2.21

Daxor Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Daxor (FRA:DX5) Business Description

Traded in Other Exchanges
Address
109 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Daxor (FRA:DX5) Headlines

No Headlines